Show
Sort by
-
SARS-CoV-2 seroreversion and all-cause mortality in nursing home residents and staff post-primary course vaccination in Belgium between February and December 2021
-
- Journal Article
- A1
- open access
Dynamics of SARS-CoV-2 IgG in nursing home residents in Belgium throughout three BNT162b2 vaccination rounds : 19-month follow-up
-
- Journal Article
- A1
- open access
Follow-up of SARS-CoV-2 antibody levels in Belgian nursing home residents and staff two, four and six months after primary course BNT162b2 vaccination
-
- Journal Article
- A1
- open access
No significant association between 25-OH vitamin D status and SARS-VoV-2 antibody response after COVID-19 vaccination in nursing home residents and staff
-
- Journal Article
- A1
- open access
Prevalence of SARS-CoV-2 antibodies among Belgian nursing home residents and staff during the primary COVID-19 vaccination campaign
-
- Journal Article
- A1
- open access
Resident and informal caregiver involvement in medication-related decision-making and the medicines’ pathway in nursing homes : experiences and perceived opportunities of healthcare professionals
-
- Journal Article
- A1
- open access
Declining prevalence of SARS-CoV-2 antibodies among vaccinated nursing home residents and staff six months after the primary BNT162b2 vaccination campaign in Belgium : a prospective cohort study
-
Dynamics of the cellular and humoral immune response after BNT162b2 mRNA Covid-19 vaccination in Covid-19 naive nursing home residents
-
Efficacy, feasibility and acceptability of the OptiMEDs tool for multidisciplinary medication review in nursing homes
-
The effects of ARBs, ACEis, and statins on clinical outcomes of COVID-19 infection among nursing home residents